MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics
MASLD in PWH is independently associated with altered advanced lipoprotein and targeted metabolic profiles, indicating a higher CVD risk in this population.
Authors
- Margery A. Connelly (ORCID: https://orcid.org/0000-0002-3917-592X)
- Samer Gawrieh (ORCID: https://orcid.org/0000-0002-2056-4909)
- Eduardo Vilar‐Gómez (ORCID: https://orcid.org/0000-0003-1435-4013)
- Kathleen E. Corey (ORCID: https://orcid.org/0000-0003-2882-7264)
- Jordan E. Lake (ORCID: https://orcid.org/0000-0002-0640-5514)
- Naga Chalasani (ORCID: https://orcid.org/0000-0003-4082-3178)
- Samir K. Gupta (ORCID: https://orcid.org/0000-0001-6031-8705)
- Kung-Hung Lin
Institutions
- Harvard University (US)
- LabCorp (United States) (US)
- Massachusetts General Hospital (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1186/s12944-024-02317-4
- Citations
- 5
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.45
Funders
- National Institutes of Health